Merck & Co., Inc. (MRK)

September 3rd, 2020


Stay up to date

Merck & Co., Inc. engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, Healthcare Services, and Alliances. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock and companion animal species. The Healthcare Services segment offers services and solutions that focus on engagement, health analytics, and clinical services to improve the value of care delivered to patients. The Alliances segment includes results from the company's relationship with AstraZeneca LP related to sales of Nexium and Prilosec. The company was founded in 1891 and is headquartered in Kenilworth, NJ.

Financial Statements

Key Info

  • Industry: Pharmaceuticals: Major
  • Sector: Health Technology
  • CEO Name: Kenneth C. Frazier

Key Statistics

  • Stock Price: $86.93
  • Dividend Yield: 2.7%
  • Market Capitalization: $219,866,833,200
  • Shares Outstanding: 2,529,240,000
  • Number of Employees: 71,000
  • Trailing 12-Month EPS: $4.12
  • Trailing 12-Month DPS: $2.38
  • Payout Ratio: 57.8%

Important Dates

  • Next Earnings Date: 2020-10-27
  • Next Ex-Dividend Date: 2020-06-12

Price Trends

  • Current Stock Price: $86.93
  • 52-week high: $92.64
  • 52-week low: $65.25
  • 200-day moving average: $81.96
  • 50-day moving average: $80.8


  • 1-Month Price Return: 5.3%
  • 3-Month Price Return: 5.9%
  • 6-Month Price Return: 9.9%
  • 1-Year Price Return: 0.3%
  • 2-Year Price Return: 24.2%
  • 5-Year Price Return: 28.5%

Visit the Passiv Stock Directory

Data provided by IEX Cloud

September 3rd, 2020